Scinai Immunotherapeutics Ltd. (SCNI)
0.4844
+0.04
(+9.84%)
USD |
NASDAQ |
Nov 09, 16:00
0.479
-0.01
(-1.11%)
After-Hours: 19:36
Scinai Immunotherapeutics Profit Margin (Quarterly) : -106.0% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -106.0% |
| June 30, 2026 | -435.4% |
| March 31, 2026 | |
| December 31, 2025 | -787.5% |
| September 30, 2025 | -764.5% |
| Date | Value |
|---|---|
| June 30, 2025 | -1.38K% |
| March 31, 2025 | -265.7% |
| December 31, 2024 | -1.08K% |
| September 30, 2024 | |
| June 30, 2024 | -817.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd. | -269.3% |
| Pluri, Inc. | -1.85K% |
| Evogene Ltd. | -458.5% |
| CollPlant Biotechnologies Ltd. | -2.52K% |
| Regentis Biomaterials Ltd. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.60% |
| Return on Assets | -16.09% |
| Return on Invested Capital | -18.14% |
| Gross Profit Margin (Quarterly) | -32.38% |
| Operating Margin (Quarterly) | -105.1% |
| Return on Net Operating Assets | -19.59% |